Literature DB >> 9585590

Evidence for autosomal dominant inheritance of prostate cancer.

D J Schaid1, S K McDonnell, M L Blute, S N Thibodeau.   

Abstract

A family-history cancer survey was conducted on 5,486 men who underwent a radical prostatectomy, for clinically localized prostate cancer, in the Department of Urology at the Mayo Clinic during 1966-95; 4,288 men responded to the survey. Complex segregation analysis was performed to assess the genetic basis of age at diagnosis and the familial clustering of prostate cancer. For the total group, no single-gene model of inheritance clearly explained familial clustering of disease, which could be partly explained by lack of Hardy-Weinberg equilibrium, with an excess of homozygotes. After accounting for deviations from Hardy-Weinberg equilibrium, the best-fitting model that explained the familial aggregation and age at diagnosis was a rare autosomal dominant susceptibility gene, and this model fitted best when probands were diagnosed at <60 years of age. The model predicts that the frequency of the susceptibility gene in the population is .006 and that the risk of prostate cancer by age 85 years is 89% among carriers of the gene and 3% among noncarriers. A strength of our study is its large size, such that genetic models could be fitted within strata defined by the age of the proband. Although the autosomal dominant model was consistently the best model, the parameter estimates differed somewhat (P=.03) across the different age groups, suggesting genetic heterogeneity. Additional evidence that the hereditary basis of prostate cancer is likely to be genetically complex was provided by the following: (1) there was a significantly elevated age-adjusted risk of prostate cancer among brothers of probands, compared with their fathers (relative risk 1.5 [95% confidence interval 1.4-1.7]); (2) the autosomal dominant model predicted an excess of homozygotes, over that predicted by Hardy-Weinberg equilibrium; and (3) the model-predicted risk of prostate cancer among relatives was inadequate when probands were diagnosed at age >=70 years.

Entities:  

Mesh:

Year:  1998        PMID: 9585590      PMCID: PMC1377141          DOI: 10.1086/301862

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  26 in total

1.  Segregation analysis of prostate cancer in Sweden: support for dominant inheritance.

Authors:  H Grönberg; L Damber; J E Damber; L Iselius
Journal:  Am J Epidemiol       Date:  1997-10-01       Impact factor: 4.897

2.  A general model for the genetic analysis of pedigree data.

Authors:  R C Elston; J Stewart
Journal:  Hum Hered       Date:  1971       Impact factor: 0.444

3.  Regressive logistic models for familial disease and other binary traits.

Authors:  G E Bonney
Journal:  Biometrics       Date:  1986-09       Impact factor: 2.571

4.  A unified model for complex segregation analysis.

Authors:  J M Lalouel; D C Rao; N E Morton; R C Elston
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

5.  Mendelian inheritance of familial prostate cancer.

Authors:  B S Carter; T H Beaty; G D Steinberg; B Childs; P C Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 6.  Epidemiologic evidence regarding predisposing factors to prostate cancer.

Authors:  B S Carter; H B Carter; J T Isaacs
Journal:  Prostate       Date:  1990       Impact factor: 4.104

7.  Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus.

Authors:  H Grönberg; S D Isaacs; J R Smith; J D Carpten; G S Bova; D Freije; J Xu; D A Meyers; F S Collins; J M Trent; P C Walsh; W B Isaacs
Journal:  JAMA       Date:  1997-10-15       Impact factor: 56.272

8.  Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis.

Authors:  R C Go; M C King; J Bailey-Wilson; R C Elston; H T Lynch
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

9.  The accuracy of patient reports of a family history of cancer.

Authors:  R R Love; A M Evans; D M Josten
Journal:  J Chronic Dis       Date:  1985

10.  Familial prostatic cancer risk and low testosterone.

Authors:  A W Meikle; W M Stanish
Journal:  J Clin Endocrinol Metab       Date:  1982-06       Impact factor: 5.958

View more
  43 in total

1.  Segregation analyses of 1,476 population-based Australian families affected by prostate cancer.

Authors:  J Cui; M P Staples; J L Hopper; D R English; M R McCredie; G G Giles
Journal:  Am J Hum Genet       Date:  2001-04-11       Impact factor: 11.025

2.  A genome screen of multiplex sibships with prostate cancer.

Authors:  B K Suarez; J Lin; J K Burmester; K W Broman; J L Weber; T K Banerjee; K A Goddard; J S Witte; R C Elston; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

3.  A genomic scan of families with prostate cancer identifies multiple regions of interest.

Authors:  M Gibbs; J L Stanford; G P Jarvik; M Janer; M Badzioch; M A Peters; E L Goode; S Kolb; L Chakrabarti; M Shook; R Basom; E A Ostrander; L Hood
Journal:  Am J Hum Genet       Date:  2000-05-19       Impact factor: 11.025

4.  Evidence for a prostate cancer-susceptibility locus on chromosome 20.

Authors:  R Berry; J J Schroeder; A J French; S K McDonnell; B J Peterson; J M Cunningham; S N Thibodeau; D J Schaid
Journal:  Am J Hum Genet       Date:  2000-05-16       Impact factor: 11.025

5.  Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer.

Authors:  R Berry; D J Schaid; J R Smith; A J French; J J Schroeder; S K McDonnell; B J Peterson; Z Y Wang; J D Carpten; S G Roberts; D J Tester; M L Blute; J M Trent; S N Thibodeau
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

6.  Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer.

Authors:  C H Bock; J M Cunningham; S K McDonnell; D J Schaid; B J Peterson; R J Pavlic; J J Schroeder; J Klein; A J French; A Marks; S N Thibodeau; E M Lange; K A Cooney
Journal:  Am J Hum Genet       Date:  2001-02-06       Impact factor: 11.025

Review 7.  Prostate cancer: a comprehensive review.

Authors:  S N Pentyala; J Lee; K Hsieh; W C Waltzer; A Trocchia; L Musacchia; M J Rebecchi; S A Khan
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

8.  A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity.

Authors:  C L Hsieh; I Oakley-Girvan; R R Balise; J Halpern; R P Gallagher; A H Wu; L N Kolonel; L E O'Brien; I G Lin; D J Van Den Berg; C Z Teh; D W West; A S Whittemore
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

9.  Genomewide linkage analysis of familial prostate cancer in the Japanese population.

Authors:  Hiroshi Matsui; Kazuhiro Suzuki; Nobuaki Ohtake; Seiji Nakata; Toshiyuki Takeuchi; Hidetoshi Yamanaka; Ituro Inoue
Journal:  J Hum Genet       Date:  2003-12-10       Impact factor: 3.172

Review 10.  Krüppel cripples prostate cancer: KLF6 progress and prospects.

Authors:  Goutham Narla; Scott L Friedman; John A Martignetti
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.